Latest filing published 09 Sept 2026 for Vaxcyte, Inc., €397k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Harpreet S. Dhaliwal is a declared insider of Vaxcyte, Inc., with filings sourced from SEC (Form 4). Over a trading history stretching from 2 March 2022 to 8 September 2026, the count stands at 11 filings.
The open-market record consists of 2 sales worth €1.2M, with no purchase. The rest of the record consists of 7 share grants and 2 option exercises. 2026 to date brings no purchases and 2 sales.
Most recently, on 9 September 2026, the filings show a share grant worth €397k in Vaxcyte, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 of 11 declarations